Effective in vitro evaluation of the risk of histamine release related to valemetostat tosylate using MRGPRX2-expressing cells
The Journal of Toxicological Sciences · 2024
DOI: 10.2131/jts.49.163 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Toxicological Sciences, 2024. Verfasst von Eri Hamamura-Yasuno und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd. Hauptthemen laut MEDLINE: Histamine Release, Anaphylaxis. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medicinal Safety Research Laboratories, Daiichi Sankyo Co., Ltd.
- Medicinal Safety, Precision Medicine, Daiichi Sankyo, Inc., USA.
- Translational Research Department, Daiichi Sankyo RD Novare Co., Ltd.
Zitieren
APA
Hamamura-Yasuno, E., Kinoshita, J., Goto, K., Fujimoto, K., Pignatello, M., Tsuchiya, Y., & Mori, K. (2024). Effective in vitro evaluation of the risk of histamine release related to valemetostat tosylate using MRGPRX2-expressing cells. The Journal of Toxicological Sciences. https://doi.org/10.2131/jts.49.163
Vancouver
Hamamura-Yasuno E, Kinoshita J, Goto K, Fujimoto K, Pignatello M, Tsuchiya Y, et al. Effective in vitro evaluation of the risk of histamine release related to valemetostat tosylate using MRGPRX2-expressing cells. The Journal of Toxicological Sciences. 2024. doi:10.2131/jts.49.163
BibTeX
@article{HamamuraYasuno2024,
author = {Hamamura-Yasuno, Eri and Kinoshita, Junzo and Goto, Koichi and Fujimoto, Kazunori and Pignatello, Michael and Tsuchiya, Yoshimi and Mori, Kazuhiko},
title = {Effective in vitro evaluation of the risk of histamine release related to valemetostat tosylate using MRGPRX2-expressing cells},
journal = {The Journal of Toxicological Sciences},
year = {2024},
doi = {10.2131/jts.49.163}
}
EUVIMED